These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 17143602

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Phase II study of capecitabine plus cisplatin in patients with gastric cancer.
    Salah-Eldin MA, Ebrahim MA, AL-Ashry MS.
    Anticancer Drugs; 2009 Mar; 20(3):191-6. PubMed ID: 19396018
    [Abstract] [Full Text] [Related]

  • 23. Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer.
    Kang YK, Ryu MH, Yoo C, Chang HM, Yook JH, Oh ST, Kim BS, Kim TW.
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1435-43. PubMed ID: 20811894
    [Abstract] [Full Text] [Related]

  • 24. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.
    Ducreux M, Van Cutsem E, Van Laethem JL, Gress TM, Jeziorski K, Rougier P, Wagener T, Anak O, Baron B, Nordlinger B, EORTC Gastro Intestinal Tract Cancer Group.
    Eur J Cancer; 2005 Feb; 41(3):398-403. PubMed ID: 15691639
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer.
    Kwon JH, Kim JH, Lee JA, Shin HC, Kim HJ, Song HH, Jung JY, Kim HY, Choi DR, Kim HS, Park YI, Zang DY.
    Cancer Chemother Pharmacol; 2010 Oct; 66(5):889-97. PubMed ID: 20091311
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer.
    Shin SJ, Jeung HC, Ahn JB, Choi HJ, Cho BC, Rha SY, Yoo NC, Roh JK, Chung HC.
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):157-65. PubMed ID: 17426971
    [Abstract] [Full Text] [Related]

  • 33. Oral fluoropyrimidines (capecitabine or S-1) and cisplatin as first line treatment in elderly patients with advanced gastric cancer: a retrospective study.
    Seol YM, Song MK, Choi YJ, Kim GH, Shin HJ, Song GA, Chung JS, Cho GJ.
    Jpn J Clin Oncol; 2009 Jan; 39(1):43-8. PubMed ID: 18997184
    [Abstract] [Full Text] [Related]

  • 34. Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer.
    Lu YS, Chen DR, Tseng LM, Yeh DC, Chen ST, Hsieh CM, Wang HC, Yeh HT, Kuo SH, Huang CS.
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1257-63. PubMed ID: 20700740
    [Abstract] [Full Text] [Related]

  • 35. Phase II study of docetaxel and capecitabine in patients with metastatic or recurrent gastric cancer.
    Kim JG, Sohn SK, Kim DH, Baek JH, Sung WJ, Park JY, Kim TB, Jung HY, Yu W, Lee KB.
    Oncology; 2005 Jun; 68(2-3):190-5. PubMed ID: 16006756
    [Abstract] [Full Text] [Related]

  • 36. Capecitabine/Cyclophosphamide/Methotrexate for patients with metastatic breast cancer: a dose-finding, feasibility, and efficacy study.
    Mariani G, Petrelli F, Zambetti M, Moliterni A, Fasolo A, Marchiano A, Valagussa P, Gianni L.
    Clin Breast Cancer; 2006 Oct; 7(4):321-5. PubMed ID: 17092399
    [Abstract] [Full Text] [Related]

  • 37. Phase II study of paclitaxel combined with capecitabine as second-line treatment for advanced gastric carcinoma after failure of cisplatin-based regimens.
    Baize N, Abakar-Mahamat A, Mounier N, Berthier F, Caroli-Bosc FX.
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):549-55. PubMed ID: 19123051
    [Abstract] [Full Text] [Related]

  • 38. Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study.
    Gunnlaugsson A, Anderson H, Lind P, Glimelius B, Johnsson A.
    Radiother Oncol; 2010 Jun; 95(3):292-7. PubMed ID: 20451275
    [Abstract] [Full Text] [Related]

  • 39. Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers.
    Pino MS, Milella M, Gelibter A, Sperduti I, De Marco S, Nuzzo C, Bria E, Carpanese L, Ruggeri EM, Carlini P, Cognetti F.
    Oncology; 2009 Jun; 76(4):254-61. PubMed ID: 19246950
    [Abstract] [Full Text] [Related]

  • 40. Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancer.
    Ocvirk J, Reberšek M, Skof E, Hlebanja Z, Boc M.
    Am J Clin Oncol; 2012 Jun; 35(3):237-41. PubMed ID: 21399488
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.